Yazan Madanat

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GERON
    Topic:
    Steering committee member/honorarium
    Date added:
    Date updated:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Stemline Therapeutics
    Topic:
    Advisory board member/honorarium
    Date added:
    Date updated:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bluprint Pharmaceuticals
    Topic:
    Advisory Board member/Honoraria
    Date added:
    Date updated:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    OncLive
    Topic:
    Consulting/invited speaker
    Date added:
    Date updated:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    MD Education
    Topic:
    Consulting/invited speaker
    Date added:
    04/25/2023
    Date updated:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Rigel Pharmaceuticals
    Topic:
    Advisory board meeting member
    Date added:
    04/25/2023
    Date updated:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Advisotry board meeting member
    Date added:
    04/25/2023
    Date updated:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Taiho
    Topic:
    Advisory board meeting member
    Date added:
    04/25/2023
    Date updated:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sierra Oncology
    Topic:
    Advisory board meeting member
    Date added:
    04/25/2023
    Date updated:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Morphosys
    Topic:
    Advisory board meeting member
    Date added:
    04/25/2023
    Date updated:
    02/29/2024
Return to 193 Hematology/Hematopathology Case Conference: "Upfront Management of MM" (102523)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.